China SXT Pharmaceuticals, Inc.
SXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723980
No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding China SXT Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 8 | 4 | −4 |
| Shares | 327.6K | 78.2K | −249.4K (−76.1%) |
| Value | $524.0K | $131.3K | −$392.7K (−74.9%) |
New holders (2)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 78,170 | $131.3K | 2.30% |
| Caitong International Asset Management Co., Ltd | 1 | $2 | 0.00% |
Sold out (6)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Citadel Advisors LLC | 150,576 | $240.9K |
| Invesco Ltd. | 85,331 | $136.5K |
| Geode Capital Management, LLC | 53,671 | $85.9K |
| XTX Topco Ltd | 22,774 | $36.4K |
| Virtu Financial LLC | 12,355 | $20.0K |
| Tower Research Capital LLC (TRC) | 1,827 | $2.92K |